Worldwide Epinephrine Autoinjector Industry to 2028 - Featuring Pfizer, Mylan, Sanofi and Hospira Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Sep 19, 2022--

The "Epinephrine Autoinjector Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's offering.

The report on the global epinephrine autoinjector market provides qualitative and quantitative analysis for the period from 2022 to 2028. The report predicts the global epinephrine autoinjector market to grow with a CAGR of nearly 8% over the forecast period from 2022-2028. The study on epinephrine autoinjector market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2022 to 2028.

The report on epinephrine autoinjector market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global epinephrine autoinjector market over the period of 2022 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global epinephrine autoinjector market over the period of 2022 to 2028. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Market Dynamics

Drivers

• The rising prevalence of anaphylaxis that occurs in cardiac arrest, allergy, and asthma will propel the growth of the market.
• The increasing geriatric population will fuel the market growth.

Restraints

• The high cost of epinephrine autoinjectors is expected to restrain the market growth during the forecast period.

Opportunities

• Development of automatic injection devices to further create growth opportunities for the market.

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the epinephrine autoinjector market.

2. Complete coverage of all the segments in the epinephrine autoinjector market to analyze the trends, developments in the global market and forecast of market size up to 2028.

3. Comprehensive analysis of the companies operating in the global epinephrine autoinjector market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Segments Covered

The global epinephrine autoinjector market is segmented on the basis of dosage, and end-user.

The Global Epinephrine Autoinjector Market by Dosage

• 0.15 Mg Epinephrine Autoinjector
• 0.3 Mg Epinephrine Autoinjector
• 0.5 Mg Epinephrine Autoinjector

The Global Epinephrine Autoinjector Market by End-User

• Hospital
• Clinics
• Individual

Company Profiles

The companies covered in the report include

• Pfizer Inc.
• Mylan Inc.
• ALK Abello
• Sanofi SA
• Lincoln Medical Ltd
• Teva Pharmaceuticals Ltd
• Antares Pharma Inc.
• Hospira Inc.
• Impax Laboratories, Inc.
• Bausch & Lomb Incorporated

For more information about this report visit https://www.researchandmarkets.com/r/sjixf7

View source version on businesswire.com:https://www.businesswire.com/news/home/20220919005618/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: CARDIOLOGY SENIORS PHARMACEUTICAL MEDICAL SUPPLIES HEALTH MEDICAL DEVICES HOSPITALS CONSUMER

SOURCE: Research and Markets

Copyright Business Wire 2022.